Literature DB >> 9950833

Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activation.

M Koide1, B A Carabello, C C Conrad, J M Buckley, G DeFreyte, M Barnes, R J Tomanek, C C Wei, L J Dell'Italia, G Cooper, M R Zile.   

Abstract

Myocardial hypertrophy is one of the basic mechanisms by which the heart compensates for hemodynamic overload. The mechanisms by which hemodynamic overload is transduced by the cardiac muscle cell and translated into cardiac hypertrophy are not completely understood. Candidates include activation of the renin-angiotensin system (RAS) and angiotensin II receptor (AT1) stimulation. In this study, we tested the hypothesis that load, independent of the RAS, is sufficient to stimulate cardiac growth. Four groups of cats were studied: 14 normal controls, 20 pulmonary artery-banded (PAB) cats, 7 PAB cats in whom the AT1 was concomitantly and continuously blocked with losartan, and 8 PAB cats in whom the angiotensin-converting enzyme (ACE) was concomitantly and continuously blocked with captopril. Losartan cats had at least a one-log order increase in the ED50 of the blood pressure response to angiotensin II infusion. Right ventricular (RV) hypertrophy was assessed using the RV mass-to-body weight ratio and ventricular cardiocyte size. RV hemodynamic overload was assessed by measuring RV systolic and diastolic pressures. Neither the extent of RV pressure overload nor RV hypertrophy that resulted from PAB was affected by AT1 blockade with losartan or ACE inhibition with captopril. RV systolic pressure was increased from 21 +/- 3 mmHg in normals to 68 +/- 4 mmHg in PAB, 65 +/- 5 mmHg in PAB plus losartan and 62 +/- 3 mmHg in PAB plus captopril. RV-to-body weight ratio increased from 0.52 +/- 0.04 g/kg in normals to 1.11 +/- 0.06 g/kg in PAB, 1.06 +/- 0.06 g/kg in PAB plus losartan and 1.06 +/- 0.06 g/kg in PAB plus captopril. Thus 1) pharmacological modulation of the RAS with losartan and captopril did not change the extent of the hemodynamic overload or the hypertrophic response induced by PAB; 2) neither RAS activation nor angiotensin II receptor stimulation is an obligatory and necessary component of the signaling pathway that acts as an intermediary coupling load to the hypertrophic response; and 3) load, independent of the RAS, is capable of stimulating cardiac growth.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Substances:

Year:  1999        PMID: 9950833     DOI: 10.1152/ajpheart.1999.276.2.h350

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Right ventricular aneurysm and atrial septal defect in a cat.

Authors:  Claude Boujon; Chris Amberger; Chris Lombard
Journal:  J Vet Cardiol       Date:  2004-11       Impact factor: 1.701

2.  Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors:  Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

Review 3.  A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.

Authors:  Fan Bai; Li Wang; Masataka Kawai
Journal:  J Muscle Res Cell Motil       Date:  2013-05-23       Impact factor: 2.698

4.  Inhibition of angiotensin II Gq signaling augments beta-adrenergic receptor mediated effects in a renal artery stenosis model of high blood pressure.

Authors:  David M Harris; Xiongwen Chen; Stéphanie Pesant; Heather I Cohn; Scott M MacDonnell; Matthieu Boucher; Leif E Vinge; Philip Raake; Susan R Moraca; Dongjun Li; Patrick Most; Steven R Houser; Walter J Koch; Andrea D Eckhart
Journal:  J Mol Cell Cardiol       Date:  2008-09-30       Impact factor: 5.000

5.  Heart Failure with Normal Ejection Fraction.

Authors:  Mauro Ortiz; Gregory L. Freeman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.